← Evidence map

ReviewFrontiers in oncology2024

Evaluation of KRAS inhibitor-directed therapies for pancreatic cancer treatment.

Szu-Aun Long et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

17 papers cite it

2024
2025
2026
this paperpooled itcites it
Full record →Abstract, authors, funding and every citing paper · PMID 38800401